Screener
Climb Bio, Inc. CLYM Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other income (expense): | ||
| Interest income | 1,514 | 2,287 |
| Foreign currency (loss) | (25) | (50) |
| Total other income, net | 1,489 | 2,237 |
| Net loss | $(13,722) | $(20,781) |
| Net loss per share, basic and diluted | $(0.20) | $(0.31) |
| Weighted-average common shares outstanding, basic and diluted | 68,207,313 | 67,462,450 |
| Comprehensive loss: |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Climb Bio, Inc.'s other income (expense)?
- Climb Bio, Inc. (CLYM) reported other income (expense) of $1.49M in Q1 2026.
- How has Climb Bio, Inc.'s other income (expense) changed year-over-year?
- Climb Bio, Inc.'s other income (expense) decreased by 33.4% year-over-year, from $2.24M to $1.49M.
- What is the long-term trend for Climb Bio, Inc.'s other income (expense)?
- Over 3 years (2021 to 2025), Climb Bio, Inc.'s other income (expense) has grown at a -12.4% compound annual growth rate (CAGR), from -$11.97M to $8.03M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Climb Bio, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude